Vancouver-based plant extraction company Pure Extracts Technologies (CSE:PULL) (OTC:PRXTF) (XFRA:A2QJAJ) (Pure Extracts or the Company), specializing in cannabis, hemp, functional mushrooms, and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pure Extracts Manufacturing Corp., has successfully delivered over 2,000 units of its newly designed high-efficiency 1-gram vape cartridges across four provinces. The Pure PullsTM brand product, named Pure Pulls Super THC 9lb Hammer, is now available for sale in Ontario, British Columbia, Alberta, and Nova Scotia.
This new distilled e-cigarette product has a potency of up to 90% THC and is made from pure extracts in its IP, consisting of over 30 proprietary formulas. It will complement the company's 1g full-spectrum oil (FSO) e-cigarette and pure chewable THC edibles, as well as pure chewable edible CBD gels.
As the trend towards more effective cartridge ammunition continues to develop, there is a strong demand for high-THC 9-pound hammers in Canada, and supplemental orders have been placed. The Hammer, weighing in at 9 pounds, is a refined THC oil that offers consumers a potent, smooth, and pleasurable experience, while also generating healthy profits for the company.
The CEO of Pure Extracts, Ben Nikolaevsky, expressed his satisfaction with the on-time delivery of the largest purchase orders in the company's history, both in terms of quantity and units. He was particularly pleased with the orders received from Canada's largest and most competitive provincial cannabis markets, which he sees as a significant achievement in the launch of their product line.
Pure Extracts, a company located just 20 minutes north of Whistler, British Columbia, has recently unveiled a state-of-the-art processing facility. This custom facility has been built to EU GMP standards and is designed to allow for the export of products and formulations - including those currently restricted in Canada - to legal and available European jurisdictions. As of September 25th, 2020, Pure Extracts has received standard processing licenses from Health Canada under the Cannabis Act, and on July 19th, 2021, received a sales amendment. The company's stock began trading on the Canadian Securities Exchange (CSE) on November 5th, 2020.
Statement
This article is compiled from third-party information and is intended solely for industry exchange and learning.
This article does not represent the views of 2FIRSTS and we cannot confirm the authenticity or accuracy of its content. The translation of this article is solely for industry exchanges and research.
Due to limited translation abilities, the translated article may not fully reflect the original text. Please refer to the original article for accuracy.
2FIRSTS shares the same opinions and positions with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and international matters.
The copyright of compiled information belongs to the original media and author. Please contact us for removal if there is any infringement.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
